Kura Oncology appoints Jennifer Fulk as chief financial officer
Kura Oncology hired Jennifer Fulk as its new chief financial officer. Fulk, 49, most recently served as chief financial officer of Soleno Therapeutics, and will receive an annual base salary of $550,000.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.